Karen Knudsen: I am disappointed by the Supreme Court’s decision to eliminate the long-standing rule of Chevron deference
Karen Knudsen, shared a post on LinkedIn:
“I am disappointed by the Supreme Court’s decision today to eliminate the long-standing rule of Chevron deference.
This rule has long helped ensure that healthcare laws are interpreted and implemented appropriately. It’s challenging for even medical and scientific professionals to keep up with constantly evolving scientific evidence.
American Cancer Society will continue to educate patients, families, caregivers, and law makers on cancer prevention, early detection, and care options in our effort to end cancer as we know it, for everyone. Thank you sci comm leaders Tim Rebbeck, Tlsty and John Burn!”
Read further.
Source: Karen Knudsen/LinkedIn
Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health.
She also served as president for the Association of American Cancer Institutes (AACI), representing the 102 leading cancer centers in North America, and on the board of directors of the American Association for Cancer Research (AACR). Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the United States.
She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards. .
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023